Integration of an EEG biomarker with a clinician's ADHD evaluation

BACKGROUND: This study is the first to evaluate an assessment aid for attention-deficit/hyperactivity disorder (ADHD) according to both Class-I evidence standards of American Academy of Neurology and De Novo requirements of US Food and Drug Administration. The assessment aid involves a method to int...

Descripción completa

Detalles Bibliográficos
Autores principales: Snyder, Steven M, Rugino, Thomas A, Hornig, Mady, Stein, Mark A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356845/
https://www.ncbi.nlm.nih.gov/pubmed/25798338
http://dx.doi.org/10.1002/brb3.330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356845/
https://www.ncbi.nlm.nih.gov/pubmed/25798338
http://dx.doi.org/10.1002/brb3.330

Ejemplares similares